West Pharmaceutical Services, Inc.WSTNYSE
Loading
Free Cash Flow Growth TrendStable
Percentile Rank64
3Y CAGR+11.2%
5Y CAGR-1.6%
Year-over-Year Change
Year-over-year free cash flow growth rate
3Y CAGR
+11.2%/yr
Quarterly compound
5Y CAGR
-1.6%/yr
Recent acceleration
Percentile
P64
Within normal range
vs 5Y Ago
0.9x
Contraction
Streak
2 qtr
Consecutive declineStable
| Period | Value |
|---|---|
| Q4 2025 | 30.69% |
| Q3 2025 | 31.40% |
| Q2 2025 | 75.39% |
| Q1 2025 | -31.81% |
| Q4 2024 | -13.77% |
| Q3 2024 | 52.47% |
| Q2 2024 | 134.78% |
| Q1 2024 | -78.83% |
| Q4 2023 | -2.90% |
| Q3 2023 | 43.18% |
| Q2 2023 | 67.50% |
| Q1 2023 | -58.79% |
| Q4 2022 | 22.32% |
| Q3 2022 | 3.83% |
| Q2 2022 | 25.29% |
| Q1 2022 | 1.30% |
| Q4 2021 | -32.45% |
| Q3 2021 | 42.63% |
| Q2 2021 | 157.35% |
| Q1 2021 | -64.14% |
| Q4 2020 | 33.33% |
| Q3 2020 | -33.68% |
| Q2 2020 | 328.80% |
| Q1 2020 | -63.66% |
| Q4 2019 | -9.95% |
| Q3 2019 | -0.52% |
| Q2 2019 | 308.51% |
| Q1 2019 | -56.48% |
| Q4 2018 | -30.21% |
| Q3 2018 | 0.16% |
| Q2 2018 | 263.53% |
| Q1 2018 | -67.31% |
| Q4 2017 | 25.30% |
| Q3 2017 | -25.63% |
| Q2 2017 | 432.14% |
| Q1 2017 | -169.14% |
| Q4 2016 | 23.35% |
| Q3 2016 | -52.18% |
| Q2 2016 | 214.44% |
| Q1 2016 | -255.17% |